Clinical trials
Phase 4 trials in Malaysia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
171 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 6 |
| 2004 | 5 |
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 6 |
| 2008 | 8 |
| 2009 | 7 |
| 2010 | 1 |
| 2011 | 6 |
| 2012 | 12 |
| 2013 | 10 |
| 2014 | 15 |
| 2015 | 10 |
| 2016 | 6 |
| 2017 | 6 |
| 2018 | 6 |
| 2019 | 10 |
| 2020 | 9 |
| 2021 | 9 |
| 2022 | 3 |
| 2023 | 12 |
| 2024 | 6 |
| 2025 | 7 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 120 |
| Unknown status | 22 |
| Recruiting | 12 |
| Terminated | 8 |
| Active, not recruiting | 5 |
| Not yet recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Malaya | 23 |
| Novartis Pharmaceuticals | 12 |
| National University of Malaysia | 10 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 7 |
| Universiti Kebangsaan Malaysia Medical Centre | 7 |
| Boehringer Ingelheim | 6 |
| Novo Nordisk A/S | 6 |
| Pfizer | 5 |
| AstraZeneca | 4 |
| GlaxoSmithKline | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 16 |
| Diabetes Mellitus | 9 |
| Coronary Artery Disease | 6 |
| Hypertension | 6 |
| Arthritis, Rheumatoid | 5 |
| Pulmonary Arterial Hypertension | 5 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| HIV Infections | 4 |
| Healthcare-Associated Pneumonia | 4 |
| Kidney Failure, Chronic | 4 |
Trials
Showing 26 to 50 of 171. Each trial links to its page on Pharma Observatory.
71 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.